These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7041432)

  • 41. [Antihypertensive efficacy of monotherapy in increasing doses versus therapy associated in low doses].
    Fasce E; Wagemann H
    Rev Med Chil; 1999 Aug; 127(8):911-8. PubMed ID: 10752251
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Antihypertensive first-line and add-on treatment with a fixed controlled release combination of metoprololsuccinate/hydrochlorothiazide. Prospective doctor's office observational study in 14,964 patients].
    Hildemann SK; Fischer HM; Bohlscheid V; Pittrow D
    MMW Fortschr Med; 2003 Apr; 145(14):42. PubMed ID: 15072279
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment of therapy-resistant hypertension].
    Weidmann P; Keusch G
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():120-31. PubMed ID: 26146
    [No Abstract]   [Full Text] [Related]  

  • 44. [Double blind randomized comparative study of two antihypertensive combinations. Enalapril-hydrochlorothiazide versus enalapril-nifedipine in 240 hypertensive patients resistant to monotherapy].
    Frances Y; Lafay V; Madona O; Chastang C; Souchet T; Chazelle F
    Therapie; 1996; 51(1):35-9. PubMed ID: 8762218
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database.
    Jackson KC; Sheng X; Nelson RE; Keskinaslan A; Brixner DI
    Clin Ther; 2008 Aug; 30(8):1558-63. PubMed ID: 18803997
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.
    Luccioni R; Sever PS; Di Perri T; Redon J; Laurandin I; Brault Y; Chastang C; Guez D
    J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effects of antihypertensive therapy on renal function in nephrogenic hypertension].
    Figarov IG; Dzhavad-Zade SM
    Urol Nefrol (Mosk); 1998; (3):27-9. PubMed ID: 9644986
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fixed combination of benazepril and very low dose hydrochlorothiazide in the treatment of mild to moderate essential hypertension: evaluation by 24-hour non invasive ambulatory blood pressure monitoring.
    Fogari R; Zoppi A; Tettamanti F; Tettamanzi D; Lusardi P; Motolese M
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):606-11. PubMed ID: 7874375
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
    Vaïsse B; Ghobrial H; Vaur L; Poncelet P; Asmar R; Herpin D; Mallion JM
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Alpha-methyldopa and renal function in arterial hypertension].
    Pessina AC; Hlede M; Pigato R; Palatini P; Dal Palù C
    Clin Ter; 1980 May; 93(3):287-94. PubMed ID: 7449342
    [No Abstract]   [Full Text] [Related]  

  • 51. The addition of a diuretic to anti-hypertensive therapy for early severe hypertension in pregnancy.
    Hall DR; Odendaal HJ
    Int J Gynaecol Obstet; 1998 Jan; 60(1):63-4. PubMed ID: 9506418
    [No Abstract]   [Full Text] [Related]  

  • 52. [Lethal polypharmacy in a patient with arterial hypertension--re the article from DMW 50/2004].
    Werner H
    Dtsch Med Wochenschr; 2005 Feb; 130(8):413; author reply 413-4. PubMed ID: 15717254
    [No Abstract]   [Full Text] [Related]  

  • 53. Methyldopa supplement for resistant essential hypertension: a prospective randomized placebo control crossover study.
    Sermswan A; Archawarak N
    J Med Assoc Thai; 2003 Dec; 86(12):1156-61. PubMed ID: 14971524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto K
    Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Time to achieve blood-pressure goal: influence of dose of valsartan monotherapy and valsartan and hydrochlorothiazide combination therapy.
    Weir MR; Levy D; Crikelair N; Rocha R; Meng X; Glazer R
    Am J Hypertens; 2007 Jul; 20(7):807-15. PubMed ID: 17586417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physicochemical and microbiological stability studies of extemporaneous antihypertensive pediatric suspensions for hospital use.
    Mendes C; Costa AP; Oliveira PR; Tagliari MP; Silva MA
    Pharm Dev Technol; 2013; 18(4):813-20. PubMed ID: 22670721
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
    Davis BR; Whelton PK;
    N Engl J Med; 2009 Mar; 360(11):1148-9; author reply 1149-50. PubMed ID: 19283889
    [No Abstract]   [Full Text] [Related]  

  • 60. The effect of losartan and losartan/hydrochlorothiazide fixed-combination on magnesium, zinc, and nitric oxide metabolism in hypertensive patients: a prospective open-label study.
    Koren-Michowitz M; Dishy V; Zaidenstein R; Yona O; Berman S; Weissgarten J; Golik A
    Am J Hypertens; 2005 Mar; 18(3):358-63. PubMed ID: 15797654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.